Added to YB: 2018-02-12
Pitch date: 2018-02-12
FLXN [bullish]
Flexion Therapeutics, Inc.
-60.66%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States.
Market Cap
$458.9M
Pitch Price
$23.18
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-4.51
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
FLEXION THERAPEUTICS INC FLXN
A summary for this pitch has not been created yet.
Read full article (0 min)